October 2, 2020

Trial Results: For women with breast cancer in the TAILORx trial, cognitive decline from chemo was early and abrupt but did not get worse over time. Cognition also declined in the group on hormone therapy alone.

Cognitive loss—or ‘brain fog’—involves memory problems, a lack of mental clarity, and difficulty keeping one’s focus. Cancer-related brain fog is common during treatment. This study dispels the idea that it is only from chemotherapy.
October 14, 2019

Lynne Alston: Why I’m grateful for researchers

Lynne Alston is a thought leader, entrepreneur, international best-selling author of A Hug Saved My Life™, cancer survivor and advocate, community ambassador, life and wellness coach, and the founder/chief executive officer of the HUGS Around America™ Foundation.
October 14, 2019

Dr. Debby Olusa: My tribute to researchers

Dr. Debby Olusa is a global thought leader, entrepreneur, international speaker, best-selling co-author of Fearless Visionaries – Volume 2, breast cancer child caregiver advocate, model, and the founder/chief executive officer of Olusa Associates, LLC.